International Prescription Drug Parity Act - Amends the Federal Food, Drug, and Cosmetic Act to require manufacturers of certain drugs manufactured and domestically approved and then exported, or domestically approved and manufactured in a registered foreign establishment, to: (1) maintain specified shipment compliance and labeling records; and (2) make such records available to U.S. importers.
Directs the Secretary of Health and Human Services to establish related criteria to facilitate the U.S. importation of such drugs.
Introduced in House
Introduced in House
Referred to the House Committee on Commerce.
Referred to the Subcommittee on Health and Environment.
Sponsor introductory remarks on measure. (CR H2186-2187)
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line